Volver a Agenda
Session Chair(s)
Leonardo Ebeling, DrMed, PHD
Managing Director
Dr. Ebeling & Assoc. GmbH, Germany
Learning Objective : Discuss a workflow to perform a continuous benefit-risk analysis in accordance with the Good Pharmacovigilance Practices; Describe a simple and effective solution to the review of clinical and regulatory documents; Discuss how outsourced PBRER reports add value to clinical development programs.
Speaker(s)
Understanding Periodic Benefit-Risk Evaluation Reports
Tony Womack
INC Research, United States
Executive Director, Medical Writing
Continuous Benefit-Risk Analysis
Leonardo Ebeling, DrMed, PHD
Dr. Ebeling & Assoc. GmbH, Germany
Managing Director
Document-Specific, Role-Based Review Matrix
Gurparkash Singh, PHD
Janssen R&D LLC, United States
Principal Medical Writing Scientist
¿Tiene una cuenta?